GGrantScoutHQCreate alert

Grants for Small businesses — Page 12

Current opportunities whose structured applicant data includes Small businesses. Confirm entity definitions, geography, registrations, exclusions and every other condition in the official notice.

459 current opportunities · showing 265–288

OPENHealth & Medical

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to elucidate a role for understudied proteins in rare disease. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s). A list of eligible proteins i

Deadline
Nov 17, 2027
Funding
Up to $100,000
Check fit and official source →
OPENHealth & Medical

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

National Institutes of Health

This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may b

Deadline
Nov 17, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities. These priorities were most recently outlined by the NIH Office of AIDS Research (OAR)

Deadline
Nov 17, 2027
Funding
See official notice
Check fit and official source →
OPENResearch & Science

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

National Institutes of Health

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support

Deadline
Nov 19, 2027
Funding
Estimated total program funding: $300,000
Check fit and official source →
OPENHealth & Medical

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this Notice of Opportunity Announcement (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescri

Deadline
Dec 4, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription

Deadline
Dec 4, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
Up to $350,000
Check fit and official source →
OPENHealth & Medical

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage UG3/UH3 phased cooperative agreement research applications to plan and implement behavioral and social intervention clinical trials. Studies appropriate for this announcement include clinical trials to develop and test behavior

Deadline
Jan 7, 2028
Funding
Up to $500,000
Check fit and official source →
OPENHealth & Medical

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

National Institutes of Health

To support UG3/UH3 phased, cooperative agreement research applications to plan and implement clinical trials within the mission of the National Institute of Dental and Craniofacial Research (NIDCR)

Deadline
Jan 7, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

National Institutes of Health

The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), and th

Deadline
Jan 7, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

National Institutes of Health

This NIDCR Small Grant Program for New Investigators supports basic and clinical research conducted by scientists who are in the early stages of establishing an independent research career in oral, dental and craniofacial research. This R03 program supports pilot or feasibility studies and developme

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENResearch & Science

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

National Institutes of Health

The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

National Institutes of Health

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvem

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENResearch & Science

NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)

National Institutes of Health

The NIH Small Research Grant Program supports small research projects that can be carried out in a short period of time with limited resources. This program supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained resear

Deadline
Jan 8, 2028
Funding
Up to $50,000
Check fit and official source →
OPENResearch & Science

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) supports projects relevant to the NIGMS mission that focus solely on the development of technologies with potential to enable acquisition of biomedical knowledge. Projects should be justified in terms of technical innovation and utility of such technical inn

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) encourages applications that will expand knowledge of the natural history of disorders that currently are, or may become, part of statewide newborn screening programs. A comprehensive understanding of the natural history of a condition is nece

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) program is to facilitate transition of highly qualified dentists from NIH Intramural postdoctoral research positions to extramural academic tenure-track or equivalent faculty positions at eligible i

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Laboratories to Optimize Digital Health (R01 Clinical Trial Required)

National Institutes of Health

NIMH seeks applications for innovative research projects to test strategies to increase the reach, efficiency, effectiveness, and quality of digital mental health interventions. This NOFO is intended to support the development of digital health test beds that leverage well-established digital mental

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENResearch & Science

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

National Institutes of Health

The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →

Before you apply

Applicant type is only the first screening step. Check location, project purpose, cost share, required partners, registration lead time and the funder’s definition of an eligible entity.